September is World Alzheimer’s Month, and the global Alzheimer’s disease community is looking to raise awareness and combat stigma related to Alzheimer’s and other forms of dementia. “This September, ...
The U.S. Food and Drug Administration (FDA) has approved Leqembi Iqlik (lecanemab-irmb), an under-the-skin autoinjector formulation for maintenance dosing in early Alzheimer’s disease. The approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback